Pharmaceuticals

Global Plant-Based Vaccines Market 2026–2035 advancing with biotech innovations

March 24, 2026March 24, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Plant-Based Vaccines Market From 2026 To 2030?

The plant-based vaccines market has seen swift expansion in recent years. This market is forecast to increase from $1.81 billion in 2025 to $1.99 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.2%. Historically, its growth was propelled by various factors including insufficient cold chain infrastructure in developing regions, the significant costs of traditional vaccine manufacturing, a rise in zoonotic disease occurrences, initial academic explorations in plant molecular farming, and governmental backing for alternative biologics.

The plant-based vaccines market size is anticipated to experience substantial growth in the upcoming years. It is projected to expand to $3.06 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.3%. This expansion during the forecast period can be linked to several factors, such as the increasing demand for adaptable vaccine platforms, the expansion of pandemic preparedness efforts, rising investments in plant biotechnology companies, the need for cost-effective veterinary vaccines, and advancements in regulatory frameworks for innovative vaccine technologies. Noteworthy trends over this period will encompass the wider application of recombinant antigen expression in plants, the growing adoption of plant-based platforms for animal vaccines, an enhanced focus on creating oral and edible vaccines, increasing public and private funding for alternative vaccine methods, and improvements in downstream processing and purification techniques.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12144&type=smp

What Key Drivers Are Influencing The Growth Of The Plant-Based Vaccines Market?

A significant presence of infectious diseases is anticipated to boost the expansion of the plant-based vaccines market in the future. These diseases are health conditions stemming from pathogenic microorganisms like bacteria, viruses, or parasites, capable of spreading through direct or indirect means and presenting considerable global health dangers. The rise in instances of infectious diseases is fueled by elements such as increased international travel, dense urban populations, and compromised immune systems within specific groups. Plant-derived vaccines provide novel platforms that are quickly scalable and adaptable for tackling these escalating health issues. As an illustration, the Centers for Disease Control and Prevention (CDC), a federal agency located in the US, reported in March 2024 that tuberculosis (TB) cases climbed from 8,320 in 2022 to 9,615 in 2023, representing an increase of 1,295 cases. Consequently, the widespread occurrence of infectious diseases is stimulating the growth within the plant-based vaccines market.

Which Segments Are Included In The Analysis Of The Plant-Based Vaccines Market?

The plant-based vaccines market covered in this report is segmented –

1) By Vaccine Type: Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types

2) By Source: Tobacco Plant, Maize, Potato, Other Sources

3) By Application: Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications

Subsegments:

1) By Bacterial Vaccines: Recombinant Bacterial Vaccines, Conjugate Bacterial Vaccines, DNA-Based Bacterial Vaccines

2) By Viral Vaccines: Inactivated Viral Vaccines, Live Attenuated Viral Vaccines, Subunit Viral Vaccines

3) By Parasite Vaccines: Recombinant Parasite Vaccines, DNA-Based Parasite Vaccines

4) By Other Vaccine Types: Fungal Vaccines, Multivalent Vaccines, Toxin-Based Vaccines

Which Trends Are Impacting The Growth Of The Plant-Based Vaccines Market?

Leading firms within the plant-based vaccines market are entering into strategic manufacturing alliances to boost clinical-stage production capacity and speed up the progress of advanced VLP-based vaccines. These strategic manufacturing collaborations are designed to improve downstream processing effectiveness, guarantee manufacturing adheres to GMP standards, and facilitate a smooth progression from initial research to clinical trials. As an example, in December 2024, Aramis Biotechnologies Inc., a Canada-based company focused on plant-based biomanufacturing of novel vaccines, formed a partnership with Biodextris Inc., another Canada-based CDMO expert in cGMP complex biologic products, with the goal of supporting Phase 1 and Phase 2 clinical trials. Through this collaboration, the partner organization will conduct purification, formulation, and fill-finish procedures for plant-expressed VLP vaccine candidates, thereby allowing for quicker scale-up, better production quality, and enhanced preparation for subsequent clinical evaluation.

Which Key Industry Participants Are Active In The Plant-Based Vaccines Market?

Major companies operating in the plant-based vaccines market are British American Tobacco PLC, Medicago Inc., Creative Biolabs Inc., Fraunhofer USA Inc., Biodextris Inc., Avesthagen Limited, Calyxt Inc., Mapp Biopharmaceutical Inc., Kentucky BioProcessing Inc., Planet Biotechnology Inc., Icon Genetics GmbH, PlantForm Corporation, LenioBio GmbH, iBio Inc., Lumen Bioscience Inc., Baiya Phytopharm Co. Ltd., Greenovation Biotech GmbH, Pevion Biotech AG, Zyus Life Sciences Inc., Agenus Inc.

Read the full plant-based vaccines market report here:

https://www.thebusinessresearchcompany.com/report/plant-based-vaccines-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Plant-Based Vaccines Market?

North America was the largest region in the plant-based vaccines market in 2025. The regions covered in the plant-based vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Plant-Based Vaccines Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12144&type=smp

Browse Through More Reports Similar to the Global Plant-Based Vaccines Market 2026, By The Business Research Company

Plant Based Proteins Market 2026

https://www.thebusinessresearchcompany.com/report/plant-based-proteins-market

Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Preventive Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/preventive-vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795